Skip to main content
Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection

Fig. 2

Vaccination with recombinant MCMV vectors via the IP and SC route induces potent specific T cell responses. Mice were vaccinated with MCMV-IE2-E7 via IP, SC or IN route or kept unvaccinated (control), and the CD8 T cell responses were examined in blood. a Representative flow cytometry plots for MHC class I multimer staining to E7, M38 and M45 epitopes in blood of MCMV-IE2-E7 infected mice via IP during acute phase (day 8 post vaccination) and memory phase (day 64 post vaccination). Numbers represent the percentage of Ag-specific CD8+ T cells within the total CD8+ T cell population. Control flow cytometry plots show the staining for E7 multimer in unvaccinated mice. Flow cytometry plots show similar numbers of total cells in each plot except for control. b Frequency of Ag-specific CD8+ T cells to E7, M38 and M45 epitopes over time. c Frequency of effector-memory (EM) cells (KLRG1+, CD62L) within E7, M38 and M45 MHC multimer+ CD8+ T cells over time. Data represents mean values ± SEM (n = 7–8 mice per group) and are representative of two independent experiments with similar results

Back to article page